Page last updated: 2024-10-28

glutethimide and Cushing Syndrome

glutethimide has been researched along with Cushing Syndrome in 2 studies

Glutethimide: A hypnotic and sedative. Its use has been largely superseded by other drugs.

Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marek, J1
Horký, K1
Gregorová, I1
Motlík, K1
Bricaire, H1
Luton, JP1
Mathieu de Fossey, B1
Rémy, JM1

Trials

1 trial available for glutethimide and Cushing Syndrome

ArticleYear
[Further experience with the long-term treatment with aminoglutethimide in hyperfunction of the adrenal cortex (author's transl)].
    Sbornik lekarsky, 1974, Volume: 76, Issue:7

    Topics: Adrenocortical Hyperfunction; Adult; Clinical Trials as Topic; Cushing Syndrome; Drug Evaluation; Fe

1974

Other Studies

1 other study available for glutethimide and Cushing Syndrome

ArticleYear
[Place of synthetic anticortisolic agents in Cushing's syndrome].
    Therapeutique (La Semaine des hopitaux), 1971, Volume: 47, Issue:1

    Topics: Cushing Syndrome; Dichlorodiphenyldichloroethane; Glutethimide; Humans; Hydrocortisone; Triparanol

1971